Elelyso®
ELELYSO® (taliglucerase alfa) for injection is a plant-based treatment option indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Pfizer Inc. |
CLASS: Enzyme Replacement Therapy |
PRESCRIBED BY: Hematologists, Oncologists, or Liver, Genetic or Orthopedic Specialists
|
HOW ADMINISTERED: Intravenous Infusion |
FREQUENCY: Every other week |
Length of infusion: 60-120 mins |
FOR MORE INFORMATION: |
